Published online before print October 19, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis
,
,
@
*Department of Molecular Bioscience, School of Bioscience and Biotechnology, and
Vascular System Research Center, Kangwon National University, Chunchon, Korea
@ To whom correspondence should be addressed. E-mail: phkim{at}kangwon.ac.kr.
TGF-
induces vascular endothelial growth factor (VEGF), a potent angiogenic factor, at the transcriptional and protein levels in mouse macrophages. VEGF secretion in response to TGF-
1 is enhanced by hypoxia and by overexpression of Smad3/4 and hypoxia-inducible factor-1
/
(HIF-1
/
). To examine the transcriptional regulation of VEGF by TGF-
1, we constructed mouse reporters driven by the VEGF promoter. Overexpression of HIF-1
/
or Smad3/4 caused a slight increase of VEGF promoter activity in the presence of TGF-
1, whereas cotransfection of HIF-1
/
and Smad3/4 had a marked effect. Smad2 was without effect on this promoter activity, whereas Smad7 markedly reduced it. Analysis of mutant promoters revealed that the one putative HIF-1 and two Smad-binding elements were critical for TGF-
1-induced VEGF promoter activity. The relevance of these elements was confirmed by chromatin immunoprecipitation assay. p300, which has histone acetyltransferase activity, augmented transcriptional activity in response to HIF-1
/
and Smad3/4, and E1A, an inhibitor of p300, inhibited it. TGF-
1 also increased the expression of fetal liver kinase-1 (Flk-1), a major VEGF receptor, and TGF-
1 and VEGF stimulated pro-matrix metalloproteinase 9 (MMP-9) and active-MMP-9 expression, respectively. The results from the present study indicate that TGF-
1 can activate mouse macrophages to express angiogenic mediators such as VEGF, MMP-9, and Flk-1.
Key Words: MMP-9 HUVEC promoter
This article has been cited by other articles:
![]() |
P. Fabbrini, M. N. Schilte, M. Zareie, P. M. ter Wee, E. D. Keuning, R. H. J. Beelen, and J. van den Born Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3669 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Murugaiyan and B. Saha Protumor vs Antitumor Functions of IL-17 J. Immunol., October 1, 2009; 183(7): 4169 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Clifford, K. Deacon, and A. J. Knox Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor {beta}1: REQUIREMENT FOR Smads, {beta}-CATENIN, AND GSK3{beta} J. Biol. Chem., December 19, 2008; 283(51): 35337 - 35353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Wu, B. L. Johnson, Y. Chen, C. T. Ha, and G. S. Dveksler Murine Pregnancy-Specific Glycoprotein 23 Induces the Proangiogenic Factors Transforming-Growth Factor Beta 1 and Vascular Endothelial Growth Factor A in Cell Types Involved in Vascular Remodeling in Pregnancy Biol Reprod, December 1, 2008; 79(6): 1054 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mu, W. Wang, and J. C. Schimenti An Allelic Series Uncovers Novel Roles of the BRCT Domain-Containing Protein PTIP in Mouse Embryonic Vascular Development Mol. Cell. Biol., October 15, 2008; 28(20): 6439 - 6451. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Moore, T. Isayeva, G. P. Siegal, and S. Ponnazhagan Silencing of Transforming Growth Factor-{beta}1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo Clin. Cancer Res., August 1, 2008; 14(15): 4961 - 4970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-A Kim, S.-H. Jeon, G.-Y. Seo, J.-B. Park, and P.-H. Kim TGF-{beta}1 and IFN-{gamma} stimulate mouse macrophages to express BAFF via different signaling pathways J. Leukoc. Biol., June 1, 2008; 83(6): 1431 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S.R. Maharaj, T. E. Walshe, M. Saint-Geniez, S. Venkatesha, A. E. Maldonado, N. C. Himes, K. S. Matharu, S. A. Karumanchi, and P. A. D'Amore VEGF and TGF-{beta} are required for the maintenance of the choroid plexus and ependyma J. Exp. Med., February 18, 2008; 205(2): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishida, J.-L. Gao, and P. M. Murphy Chemokine Receptor CX3CR1 Mediates Skin Wound Healing by Promoting Macrophage and Fibroblast Accumulation and Function J. Immunol., January 1, 2008; 180(1): 569 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Yeh, D.-Y. Lu, C.-J. Lin, H.-C. Liou, and W.-M. Fu Inhibition of Hypoxia-Induced Increase of Blood-Brain Barrier Permeability by YC-1 through the Antagonism of HIF-1{alpha} Accumulation and VEGF Expression Mol. Pharmacol., August 1, 2007; 72(2): 440 - 449. [Abstract] [Full Text] [PDF] |
||||